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ctin ﬁlament pointed-end dynamics are thought to
play a critical role in cell motility, yet regulation of
this process remains poorly understood. We describe
here a previously uncharacterized tropomodulin (Tmod)
isoform, Tmod3, which is widely expressed in human tissues
and is present in human microvascular endothelial cells
(HMEC-1). Tmod3 is present in sufﬁcient quantity to cap
pointed ends of actin ﬁlaments, localizes to actin ﬁlament
structures in HMEC-1 cells, and appears enriched in leading
edge rufﬂes and lamellipodia. Transient overexpression of
GFP–Tmod3 leads to a depolarized cell morphology and
decreased cell motility. A ﬁvefold increase in Tmod3 results
A
 
in an equivalent decrease in free pointed ends in the cells.
Unexpectedly, a decrease in the relative amounts of F-actin,
free barbed ends, and actin-related protein 2/3 (Arp2/3)
complex in lamellipodia are also observed. Conversely,
decreased expression of Tmod3 by RNA interference leads
to faster average cell migration, along with increases in free
pointed and barbed ends in lamellipodial actin ﬁlaments.
These data collectively demonstrate that capping of actin
ﬁlament pointed ends by Tmod3 inhibits cell migration and
reveal a novel control mechanism for regulation of actin
ﬁlaments in lamellipodia.
 
Introduction
 
Cell migration is a complex, multistep process that is essential
for many aspects of development in multicellular organisms.
One step, which appears to be common to many types of
cell migration, is the protrusion of lamella from cell bodies
using an F-actin–rich lamellipodia (Small et al., 2002).
Lamellipodial protrusion is driven by actin filament barbed-
end assembly at the leading edge of migrating cells and is
 
governed by several actin regulatory proteins. A key component
is the actin-related protein 2/3 (Arp2/3)* complex, which
nucleates the formation of new filaments in response to
activated WASP or SCAR (for reviews see Carlier and
Pantaloni, 1997; Pollard et al., 2000; Condeelis, 2001). In
addition, cofilin/actin-depolymerizing factor (ADF) also
provides new barbed ends for polymerization by filament
severing (Chan et al., 2000; Ichetovkin et al., 2002). Together,
these regulatory proteins cause rapid creation of actin filament
barbed ends and assembly from these new barbed ends,
which then provide force to push the membrane forward
(Theriot, 2000).
Although the force of protrusion is provided by barbed-
end polymerization, filaments must also be disassembled
from their pointed ends to replenish the monomer pool
and move the network forward. Indeed, analysis of poly-
merization and depolymerization rate constants indicates
that filament disassembly from the pointed ends may be the
rate-liming component in an actin filament treadmilling model
(Pantaloni et al., 2001). To overcome this limitation, motile
cells utilize several mechanisms to enhance the disassembly
of the actin filaments in lamellipodia. First, filament severing
by cofilin/ADF directly provides additional free pointed
ends (Bamburg, 1999; Chan et al., 2000; Condeelis,
2001). Second, cofilin/ADF may also enhance subunit
dissociation from existing pointed ends, which are occupied
by ADP-actin subunits (Carlier et al., 1997; Maciver,
1998). Third, stochastic debranching of filaments linked
by Arp2/3 can also provide pointed ends from which fila-
ments can depolymerize. Debranching may be enhanced
by nucleotide hydrolysis and phosphate release by actin
subunits in daughter filaments at branch points (Blanchoin
et al., 2000b). Conversely, cells may use several mechanisms
to negatively regulate pointed-end disassembly and thus
inhibit motility. For example, a well-characterized mechanism
is the phosphorylation of cofilin/ADF, which inhibits its
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activity and prevents lamellipodial extension (Bamburg,
1999; Zebda et al., 2000).
An unexplored mechanism for negative regulation of
pointed-end disassembly is pointed-end capping. Currently,
tropomodulin (Tmod) is the only protein known whose sole
function is to cap pointed ends of actin filaments (Weber et
al., 1994; Littlefield et al., 2001). It was previously thought
that Tmod was only involved in capping the pointed ends of
filaments in stable, nondynamic cytoskeleton structures be-
cause it was originally found associated with actin filaments
that are strictly regulated in length and persist over many days
(e.g., erythrocyte membrane skeletons and striated muscle sar-
comere thin filaments; Fowler, 1996). However, photobleach-
ing experiments with GFP–Tmod and in vivo incorporation
of fluorescently labeled actin in cardiac muscle cells have
shown that Tmod capping is dynamic, and that the pointed
ends that it occupies are sites of active assembly and disassem-
bly (Littlefield et al., 2001). An interesting consequence of dy-
namic capping by Tmod is that the nucleotide at the pointed
ends is converted from ADP-P
 
i
 
 to ADP (due to the slower
rates of monomer association), thus leading to an increase in
the pointed-end critical concentration and a decrease of F-actin
at steady state in vitro (Weber et al., 1999).
We investigated the possibility that a Tmod isoform may be
expressed in motile, nonmuscle cell types, as it would offer
unique insights into the role of pointed-end dynamics in cell
motility. We find that Tmod3 is expressed in motile endothelial
cells, where it localizes to ruffles and lamellipodia. We demon-
strate by modulation of Tmod3 levels that endothelial cell mi-
gration rates correlate inversely with the extent of pointed-end
capping. Unexpectedly, F-actin and free barbed ends in the
lamellipodia are also inversely correlated with Tmod3 levels,
i.e., increased pointed-end capping decreases both lamellipodial
free barbed ends and F-actin. These data indicate that regula-
tion of pointed-end disassembly in lamellipodia is coordinated
with the generation of free barbed ends and F-actin and is a key
step in actin-mediated cell polarization and migration.
 
Results
 
Tmod3 is a pointed-end capping protein expressed 
in endothelial cells
 
Previous studies have identified a family of four canonical
Tmod genes in vertebrate species, based on homology to
 
known cDNA sequences (Cox and Zoghbi, 2000; Conley
et al., 2001). A new isoform identified in vertebrates was
designated as Tmod3. Like other Tmod isoforms, Tmod3
inhibits elongation from the pointed ends of gelsolin-
capped actin filaments in a concentration-dependent man-
ner (Fig. 1 A). When initial rates of elongation as a
function of Tmod3 concentration are analyzed by double
reciprocal plots, the K
 
d
 
 of Tmod3 for capping pointed
ends of actin filaments is 
 
 
 
110 nM. This is similar to the
K
 
d
 
s for capping pointed ends of Tmod1 (K
 
d
 
 
 
 
 
 180 nM)
and Tmod4 (K
 
d
 
 
 
 
 
 80 nM) (Fig. 1 A; Weber et al., 1999).
However, whereas other Tmod isoforms are restricted to
only a few differentiated cell types, Tmod3 was found in
nearly all tissues tested (Cox and Zoghbi, 2000; Conley et
al., 2001; unpublished data).
Upon further inspection of the tissues most enriched for
Tmod3 expression, we observed that these tissues were also
highly vascularized. Furthermore, sections of rat spleen,
lung, or intestine stained with antibodies raised against re-
combinant human Tmod3 display prominent staining in
the cells lining blood vessels (Fig. 1 B; unpublished data)
and recognize a polypeptide of 
 
 
 
40 kD in immunoblots of
whole spleen (Fig. 1 C). Consistent with this, a human mi-
crovascular endothelial cell line (HMEC-1) contains a 40-
kD polypeptide recognized by this antibody (Fig. 2 A).
As these polyclonal antibodies to Tmod3 also cross-react
weakly with purified recombinant human Tmod1 protein
(Fig. 2 A, left), HMEC-1 cells were probed with mono-
clonal antibodies specific to Tmod1 (Fig. 2 A, right). How-
ever, no Tmod1 is detected in HMEC-1 cells (Fig. 2 A,
right). Given the very narrow tissue distribution of Tmod2
and Tmod4 expression in neurons and skeletal muscle, re-
spectively (Cox and Zoghbi, 2000; Conley et al., 2001), our
data suggest that Tmod3 is the only known isoform ex-
pressed in these endothelial cells.
We determined the concentration of endogenous Tmod3
in HMEC-1 cells by quantitative immunoblotting. The
amounts of total Tmod3 in known numbers of cells were
compared with standards of recombinant purified human
Tmod3 loaded on the same gel (Fig. 2 B, 
 
 
 
). Using a mean
cell volume determined from the mean cell diameter (mea-
sured by light microscopy of trypsinized cells), we estimate
that the total intracellular Tmod3 concentration is 
 
 
 
0.5
 
 
 
M. Because the affinity of Tmod3 for actin filament
Figure 1. Tmod3 is a novel Tmod 
isoform expressed in endothelial cells. 
(A) Tmod3 caps actin filament pointed 
ends with a similar affinity as Tmods 1 
and 4. Pointed-end capping activities of 
human Tmod3 ( , large dash), human 
Tmod1 ( , small dash), and chicken 
Tmod4 ( , solid). The extent of pointed-
end capping is plotted as the initial rate of 
elongation in the presence of Tmod, di-
vided by the initial rate of elongation for 
the control actin (R/CR), versus increasing 
Tmod concentration, such that when R/
CR   0, 100% of pointed ends are capped. 
(B) Cryosection of rat spleen stained with 
polyclonal anti-Tmod3 antibodies. Bar, 
150  m. (C) Immunoblot of total rat 
spleen protein with anti-Tmod3 antibody.T
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pointed ends is 
 
 
 
110 nM, this indicates that there is suffi-
cient Tmod3 to cap pointed ends in HMEC-1 cells.
 
Tmod3 localizes to dynamic F-actin structures 
in HMEC-1 cells
 
Migrating HMEC-1 cells have small, transient lamellipodia,
which often collapse into ruffles. Although these protrusions
and ruffles are rich in F-actin, HMEC-1 cells also contain
bundles of F-actin that are generally oriented perpendicular
to the direction of movement (Fig. 3, top, F-actin). To de-
termine which populations of actin filaments in these cells
might be targets for Tmod3 regulation, we localized endoge-
nous Tmod3 in HMEC-1 cells by indirect immunofluo-
rescence. In general, Tmod3 localizes preferentially to the
F-actin–rich structures at the forward periphery of the cell,
including lamellipodia (Fig. 3, top two rows, arrowheads)
and subsequent ruffles (arrows) that form from their col-
lapse. In contrast, Tmod3 does not localize prominently to
the perpendicular F-actin bundles in the cell body. In most
cells, a large diffuse staining component in the cytoplasm is
also observed, likely due to fixation of a portion of the solu-
ble pool (see below).
To further characterize Tmod localization, a fusion pro-
tein of GFP and Tmod3 was expressed transiently in
HMEC-1 cells. As shown in Fig. 3, the localization of the
fusion protein in lamellipodial protrusions and ruffles is sim-
ilar to endogenous Tmod3 (Fig. 3, third and fourth rows),
suggesting that GFP–Tmod3 can be used as a marker for en-
dogenous Tmod3. Therefore, using transient expression of
GFP–Tmod3, we compared its localization to the p34 sub-
unit of the Arp2/3 complex in HMEC-1 cells. In extending
lamellipodia, p34 localizes to the very edge of the cell (Fig.
3, bottom), as expected (Welch et al., 1997; Bailly et al.,
1999). GFP–Tmod3 localizes throughout the lamellipodia
but, interestingly, appears slightly enriched in a region im-
mediately behind the p34 (Fig. 3).
Tmod3 localization to dynamic cellular structures is fur-
ther supported by observations of live cells expressing GFP–
Tmod3, where its localization in leading edge ruffles and
protrusions is clearly evident (Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200209057/DC1). In cells
expressing robust levels of GFP–Tmod3, there exists a large
pool of soluble GFP–Tmod3, consistent with biochemical
fractionation experiments (see below). Interestingly, GFP–
Tmod3 also appears in highly motile dorsal protrusions and
ruffles, similar to those observed with GFP-tagged capping
protein or Arp2/3 subunits (Schafer et al., 1998). The signif-
icance of these structures with respect to Tmod3 function is
not clear at present.
 
Increasing intracellular concentration of Tmod3 
inhibits cell motility
 
HMEC-1 cells have been shown to have an average ran-
dom migration velocity of 
 
 
 
10–20 
 
 
 
m/h, depending on
the  substrate (Kiosses et al., 1999). Under our conditions,
HMEC-1 cells were observed to translocate at a similar rate
(Video 2, available at http://www.jcb.org/cgi/content/full/
jcb.200209057/DC1; Fig. 4, A and B). HMEC-1 cells dis-
played various motile behaviors, including polarization, pro-
trusion, contraction, and detachment (Video 2; Fig. 4 A).
When adenoviral vectors were used to transiently overexpress
GFP–Tmod3, HMEC-1 cells were generally less polarized in
Figure 2. Tmod3 is expressed in HMEC-1 cells. (A) Immunoblot of 
cell lysates or purified recombinant proteins with either anti-Tmod3 
polyclonal (left) or anti-Tmod1 monoclonal (right) antibodies. Mg
2  
ghosts, human erythrocyte membranes (Babcock and Fowler, 1994); 
Tmod1, purified recombinant human Tmod1 protein; Tmod3, 
purified recombinant human Tmod3 protein. (B) Quantitation of 
Tmod3 in HMEC-1 cells.  , average counts from duplicate standards 
of purified recombinant human Tmod3; dashed lines indicate average 
counts from immunoblot bands of 2   10
5 and 5   10
5 HMEC-1 
cells. Line fitted to standards by least squares method was used to 
determine the amount of Tmod in HMEC-1 cells in the linear range 
of the assay.
Figure 3. Localization of Tmod3 in HMEC-1 cells. HMEC-1 cells 
were fixed and stained with fluorescent phallacidin and anti-Tmod3 
polyclonal antibodies followed by fluorescent anti–rabbit IgG anti-
bodies. GFP–Tmod3 colocalizes similarly with fluorescent phalloidin. 
Arrows indicate ruffles, arrowheads indicate small lamellipodia. In 
the bottom row, Tmod3 localizes to the lamellipodia, including a 
region behind Arp2/3. Cells expressing low levels of GFP–Tmod3 
were fixed and stained with anti-p34 polyclonal antibodies. Bars, 8  m.T
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morphology and adopted a more stationary, spreading mor-
phology (Fig. 4, C and D), although protrusion and ruffling
activity at the cell periphery continued in many of these cells
(Video 3, available at http://www.jcb.org/cgi/content/full/
jcb.200209057/DC1). However, whereas only a small fraction
(
 
 
 
4%) of control cells failed to exhibit protrusive activity over
a 2-h window, 
 
 
 
22% of GFP–Tmod3-overexpressing cells
failed to exhibit significant protrusive activity (see Materials
and methods) during the same time period. Those cells that do
transiently polarize by protruding lamellipodia often quickly
lose polarity and then attempt to polarize in another direction
(Video 3). Furthermore, when rates of cell translocation were
measured in the overexpressing cells, the average rate was ap-
proximately half of that observed for control cells (Fig. 4 B).
Although there was some variability in individual cell velocities
 
(as demonstrated by the large data range), the average velocity
difference between control cells and GFP–Tmod3-overex-
pressing cells was statistically significant (P 
 
 
 
 3 
 
 
 
 10
 
 
 
7
 
). Sim-
ilar effects on cell motility and morphology were also observed
with viruses expressing untagged Tmod3 (unpublished data).
 
Increasing Tmod3 concentration decreases total free 
pointed ends in vivo
 
To determine whether an increase in Tmod3 leads to in-
creased capping of existing free pointed ends in HMEC-1
cells, we used DNase I as a marker for free pointed ends in
cells in situ (Chan et al., 2000). In control HMEC-1 cells,
DNase I–stained free pointed ends are located throughout
the cell, with a concentration at the cell periphery, both at
the anterior edge and in apparent tail extensions (Fig. 5 D).
As expected, DNase I also prominently stained cell nuclei,
which were identified with DAPI staining (Fig. 5, B and E).
In cells in which GFP–Tmod3 was overexpressed, there was
a decrease in DNase I staining (Fig. 5, compare A with B)
that was particularly significant in regions where GFP–
Tmod3 was found (e.g., at the cell periphery; Fig. 5 C).
Note that the extraction of monomers before staining with
this procedure causes some cytoplasmic GFP–Tmod3 to col-
lapse onto the nucleus (Fig. 5 C), but this is not normally
observed in live or fixed cells (e.g., compare with Fig. 3).
When regions of nuclear staining are excluded, the DNase I
staining intensity can thus be used to quantitate the relative
levels of free pointed ends in the cells. When compared with
control-infected cells, cells overexpressing GFP–Tmod3 ex-
hibit a fivefold reduction in free pointed ends (Fig. 5 F),
roughly proportional to the increase in cytoskeleton-associ-
ated Tmod3 in the cells (see below). These data suggest that
GFP–Tmod3 caps a large proportion of the available
pointed ends in actin structures throughout the cell, includ-
ing at the leading edge.
 
Transient overexpression of Tmod3 does not alter 
cytoskeleton-associated F-actin levels in whole cells
 
Because the adenovirus (Ad)-mediated expression of GFP–
Tmod3 results in consistent overexpression in virtually all
cells in an experiment, we were able to use a biochemical ap-
Figure 4. HMEC-1 cell morphology and migration rate are altered 
by transient overexpression of GFP–Tmod3. Stills of supplemental 
videos (available at http://www.jcb.org/cgi/content/full/
jcb.200209057/DC1) of control cells (A, Video 2) or GFP–Tmod3 
cells (C and D, Video 3). Bar, 10  m. (B) Graph of average cell 
migration rate of control-infected or GFP–Tmod3-overexpressing 
HMEC-1 cells. Box and whisker plots were generated as described 
in the Materials and methods. n   22 cells for each measurement.
Figure 5. Tmod3 caps actin filament 
pointed ends in vivo. (A–C) Permeabilized 
cell expressing GFP–Tmod3 stained with 
DNase I or coumarin–phalloidin and 
DAPI. (A) Rhodamine–DNase I; (B) DAPI   
phallacidin; (C) GFP–Tmod3. (D and E) 
Permeabilized control-infected cell 
stained with DNase I (D) and coumarin–
phalloidin (E). DAPI staining labels 
nuclei in the same channel as coumarin–
phalloidin. Bar, 15  m. (F) Quantitation 
of nonnuclear DNase I staining in control 
and GFP–Tmod3-expressing cells. 
Values are averages from  20 cells for 
each cell type, standard deviation is 
shown by error bars.T
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proach to compare the relative level of Tmod3 expression in
both control and overexpressing cells by quantitative immu-
noblot analyses. This showed that overexpression of GFP–
Tmod3 results in approximately a fivefold increase in total
Tmod3 expression (Fig. 6, A and B). Fractionation studies
using Triton X-100 revealed that 
 
 
 
30–40% of endogenous
Tmod3 was associated with the cytoskeleton in control cells
(Fig. 6 B). When GFP–Tmod3 was overexpressed, a five- to
sixfold increase in total cytoskeleton-associated Tmod3 was
observed (Fig. 6 B), with a proportional increase in the solu-
ble pool as well. These data are consistent with the relative
decrease observed in free pointed ends in the cell (Fig. 5 F).
Interestingly, the overall distribution (soluble versus insolu-
ble) of Tmod3 in overexpressing cells was not substantially
different from control cells.
Despite a significant increase in the total amount of
Tmod3 associated with the cytoskeleton and a correspond-
ing decrease in free pointed ends upon overexpression of
GFP–Tmod3, the proportion of actin in the Triton-insolu-
ble fraction in HMEC-1 cells was not significantly altered
(Fig. 6 B). Furthermore, overall F-actin staining patterns
and levels were not observably different (Fig. 3; unpublished
data). These data suggest that although increased Tmod3
caps a large proportion of previously free pointed ends in
cells, most of the filamentous actin in the cell is not dramat-
ically affected by increased pointed-end capping.
 
Excess Tmod3 in HMEC-1 cells decreases F-actin but 
not G-actin in the lamellipodia
 
Because Tmod3 localizes to lamellipodia, we investigated
the F-actin and G-actin content of this cell compartment in
closer detail by quantitative fluorescence microscopy. Flu-
orescently labeled vitamin D–binding protein (Alexa
 
®
 
–
DBP), which binds to G-actin and not pointed ends of ac-
tin filaments (Goldschmidt-Clermont et al., 1985), was
used as a reporter for local G-actin (Cao et al., 1993).
When cells are fixed to retain G-actin and stained with
Alexa
 
®
 
–DBP and fluorescent phalloidin, relative G- or
F-actin contents of lamellipodia from control or GFP–Tmod3-
overexpressing cells can be compared (see Materials and
methods). In cells overexpressing GFP–Tmod3, no signifi-
cant change was observed in the G-actin levels in their
lamellipodia, relative to those in control cells (Table I),
consistent with our biochemical fractionation data for
whole cells. However, as determined by phalloidin staining,
the relative level of F-actin in the lamellipodia of cells over-
expressing GFP–Tmod3 was about threefold less than in
the lamellipodia of control cells (Table I). Thus, although
no alteration in global F-actin is observed (Fig. 6), the dy-
namic actin structures in the lamellipodia are significantly
affected. Previous studies have found some differences
when comparing phalloidin staining using different perme-
abilization/fixation protocols (Small et al., 1995). Under
conditions used here to stain for free barbed ends, we also
observed a similar decrease in the relative level of F-actin in
the lamellipodia of cells overexpressing Tmod3 compared
with those of control cells (unpublished data). This is reas-
suring because the two protocols are performed under
different conditions, i.e., on unfixed, permeabilized cells
(barbed ends) or on paraformaldehyde-fixed cells (G-actin).
Interestingly, these data would suggest that the G/F ratio in
the lamellipodia of cells overexpressing GFP–Tmod3 could
be significantly higher than that found in control cell
lamellipodia.
 
Excess Tmod3 alters availability of barbed ends at cell 
periphery and in lamellipodia
 
Given the migration and polarization defects exhibited by the
GFP–Tmod3-overexpressing cells, we analyzed the localiza-
tion and relative levels of free barbed ends in these cells com-
pared with control cells. When cells are permeabilized and in-
cubated with labeled actin monomers at concentrations just
above the barbed-end critical concentration, polymerization
in situ from available barbed ends can be visualized (see Mate-
rials and methods; Symons and Mitchison, 1991). Incorpora-
tion of rhodamine–ATP-actin in permeabilized HMEC-1
cells demonstrates that free barbed ends are located through-
out the cell, but that the most prominent population occurs at
cell edges (Fig. 7 A), as expected from previous studies (Sy-
mons and Mitchison, 1991). In cells overexpressing GFP–
Tmod3, this distribution is altered such that the width and in-
Figure 6. Overexpression of GFP–Tmod3 and fractionation of 
HMEC-1 cells. (A) Immunoblot of total cell lysate of cells transiently 
expressing either GFP or GFP–Tmod. For both endogenous Tmod3 
and GFP–Tmod3, some proteolysis was observed. When GFP–
Tmod is overexpressed, an apparent decrease in the endogenous 
Tmod3 is observed, but overall levels of Tmod3 are increased 
approximately sixfold. (B) Representative experiment showing 
[
125I]protein A–probed immunoblot quantitation of Tmod3 and actin 
in cells overexpressing GFP or GFP–Tmod3. cpm, 
125I counts per 
minute (detection of anti-Tmod3 anti-actin antibodies). Dark bars, 
Triton-insoluble fraction; light bars, Triton-soluble fraction. For 
GFP–Tmod3 cells, data shown are the total of both GFP–Tmod 
(arrowhead) and endogenous Tmod (*) bands in a given fraction.
 
Table I. 
 
Lamellipodial actin analyses
Actin parameter Control cells GFP–Tmod3 cells
 
F-actin
 
a
 
 (
 
n
 
) 309 
 
 
 
 84 (23) 104 
 
 
 
 46 (33)
G-actin (
 
n
 
) 104 
 
 
 
 46 (23) 98 
 
 
 
 39 (33)
Barbed ends/F
 
b
 
 (
 
n
 
) 2.98 
 
 
 
 1.20 (48) 1.43 
 
 
 
 0.81 (40)
p34
 
c
 
 (
 
n
 
) 186 
 
 
 
 117 (28) 57.6 
 
 
 
 31.4 (41)
Average values reported are in arbitrary units, with standard deviations
given. 
 
n
 
 denotes number of cells. Barbed ends/F were measured from
ratiometric images that were the result of rhodamine–actin/phalloidin.
 
a
 
P 
 
 
 
 8.2 
 
 
 
 10
 
 
 
9
 
.
 
b
 
P 
 
 
 
 1.2 
 
 
 
 10
 
 
 
9
 
.
 
c
 
P 
 
 
 
 5.3 
 
 
 
 10
 
 
 
9
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tensity at cell edges are dramatically decreased (Fig. 7 B). The
observed decrease in free barbed ends is not simply due to the
decrease in lamellipodial F-actin (Table I), because the ratio of
free barbed ends to F-actin also displays a decrease in intensity
and width at the cell edge. This is demonstrated clearly by
quantitative line scans (along radial lines perpendicular to the
membrane) performed on ratiometric images (Fig. 7 C). Fur-
thermore, quantitation of the ratio of free barbed ends to
F-actin in whole lamellipodia indicates that cells overexpress-
ing Tmod3 exhibit a twofold decrease in free barbed ends per
relative unit of filamentous actin when compared with cells
expressing endogenous levels of Tmod3 (Table I). In contrast,
when the total amount of rhodamine–actin incorporation per
cell is measured as a function of total cell area (to eliminate the
effects of cell size and spreading), only an 
 
 
 
16% decrease is
observed between control cells and GFP–Tmod3-overexpress-
ing cells (unpublished data). These data indicate that changes
in free barbed ends upon overexpression of GFP–Tmod3 are
confined to the cell periphery.
Previous studies using in vitro polymerization assays have
shown that Tmod1 does not interact with actin filament
barbed ends, nor does it bind to monomers (Weber et al.,
1994, 1999). Thus, the surprising result that increased levels
of Tmod3 reduced free barbed ends in the lamellipodia sug-
gested that Tmod3 might affect other components involved
in the generation of free barbed ends in lamellipodia. Using a
polyclonal antibody to the p34 subunit of the Arp2/3 com-
plex, we measured the relative levels of endogenous Arp2/3 in
cell lamellipodia. In both control and GFP–Tmod3-overex-
pressing cells, p34 is present in the lamellipodia (Fig. 8).
However, in cells overexpressing GFP–Tmod3, the band of
p34 staining was considerably less intense and narrower (Fig.
8), similar to the decrease in rhodamine–actin incorporation
(Fig. 7). When the average intensity per unit area in the lamel-
lipodia is quantitated, there is approximately threefold less
Arp2/3 in the lamellipodia of GFP–Tmod3-overexpress-
ing cells than in those of control cells (Table I). The total
amount of Arp2/3 per cell is not significantly different (un-
published data). Thus, by increasing Tmod3 levels transiently
in HMEC-1 cells, Arp2/3 complex appears to be displaced
from the leading lamellipodia, which may result in the genera-
tion of fewer barbed ends in these structures.
 
Decreased Tmod3 in HMEC-1 cells results in faster 
migration rates
 
To determine whether endogenous Tmod3 similarly antag-
onizes cell migration in HMEC-1 cells, we decreased
Tmod3 expression levels using small interfering RNA
(siRNA) duplexes, as previously described (Elbashir et al.,
2002). Transfection of siRNA duplexes onto HMEC-1
cells decreased Tmod3 levels to 
 
 
 
15% (or less) of control
transfected cells (Fig. 9 A). Examination of cells by immun-
ofluorescence staining for Tmod3 revealed that at least
70% of cells were transfected (see Materials and methods;
unpublished data). Cells transfected with siRNA(Tmod3)
were observed by time-lapse photomicroscopy to determine
if the decrease in Tmod3 levels had an effect on cell migra-
tion rates. Indeed, these cells exhibited a significantly in-
creased average cell velocity compared with control trans-
fected cells (Fig. 9 B). Thus, reduced Tmod3 levels lead to
the opposite effects induced by Tmod3–GFP overexpres-
sion, indicating that both endogenous and overexpressed
Tmod3 exert an inhibitory effect on cell migration.
To determine if endogenous Tmod3 inhibits HMEC-1
cell motility by a similar mechanism to overexpressed
Tmod3, we first measured free pointed ends using DNase I
staining, as above, in either mock-transfected or siRNA
(Tmod3)-transfected cells. Significantly, HMEC-1 cells
transfected with siRNA(Tmod3) exhibited an approximately
Figure 7. Analyses of free barbed ends 
in HMEC-1 cells by rhodamine–actin 
incorporation in situ. (A and B) Control 
or GFP–Tmod3-expressing HMEC-1 
cells permeabilized and labeled with 
rhodamine–actin. (C) Representative line 
scans of rhodamine–actin/fluorescent 
phallacidin ratio at the edge of the cell. 
Traces were taken from outside cell 
(near y axis) to inside cell (representative 
regions of line scans shown as white bars 
in A and B). See Table I for quantitation of 
ratiometric data from whole lamellipodia.
Figure 8. GFP–Tmod3 overexpression decreases Arp2/3 complex 
staining in lamellipodia. Control cells (A) or GFP–Tmod3-
overexpressing cells (B) were stained for Arp2/3 using anti-p34 
polyclonal antibodies. Arrowheads mark width of p34 staining in 
the lamellipodia. Bar, 10  m.T
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two-fold increase in free pointed ends per cell compared
with mock-transfected cells (Fig. 9 C). Furthermore, using
the rhodamine–actin incorporation assay described above,
we observed that the siRNA(Tmod3)-transfected cells dis-
played a modest (
 
 
 
1.5-fold), but significant, increase in free
barbed ends (measured as a ratio to F-actin) in their lamelli-
podia (Fig. 9 D). Thus, when Tmod3 levels are reduced,
more free pointed ends and free lamellipodial barbed ends
are created, concomitant with faster average cell migration
rates.
 
Discussion
 
Disassembly of actin filaments is critical to the turnover of
filament networks in lamellipodia and is required for cell
migration (Cramer, 1999). Current treadmilling models for
filament turnover predict that disassembly of actin filament
pointed ends is a rate-limiting step (Borisy and Svitkina,
2000; Pantaloni et al., 2001), yet no pointed-end regulators
have been identified previously in motile cells. We demon-
strate that Tmod3 is a bona fide actin filament pointed-end
capping protein present in motile cells in sufficient concen-
tration to cap actin filament pointed ends. Furthermore,
Tmod3 is associated with dynamic actin structures in lamel-
lipodia. Functional analyses of cell migration rates and
pointed-end capping in permeabilized cells show that in-
creases in levels of Tmod3 lead to more pointed-end cap-
ping, resulting in slower cells, whereas decreases in levels of
Tmod3 lead to less pointed-end capping, resulting in faster
cells. The simplest interpretation of our observations is that
pointed-end capping by Tmod3 reduces the rates of actin
pointed-end disassembly in lamellipodia, consistent with the
hypothesis that this is a rate-limiting step in the turnover of
lamellipodial actin filaments in migrating cells.
The unexpected finding that Tmod3 levels are inversely
correlated with the amount of F-actin and free barbed ends
in the lamellipodia is intriguing. One possible explanation is
that increased Tmod3 levels transiently cap existing pointed
ends with greater frequency, slowing their depolymerization
rate (Weber et al., 1999; Littlefield et al., 2001). This would
lead to longer-lived filaments, thus increasing the proportion
of ADP-actin subunits within these filaments, particularly
near their pointed ends. Indeed, dynamic capping by high
levels of Tmod1 in vitro has been shown to increase the pro-
portion of ADP subunits at pointed ends at steady state
(Weber et al., 1999). Because Arp2/3 branching and nucle-
ation is favored from ATP or ADP-P
 
i
 
 subunits on filaments
(Ichetovkin et al., 2002), longer-lived filaments with more
ADP-actin subunits would likely reduce Arp2/3-mediated
branching of the network. A reduced amount of branching
would result in fewer free barbed ends at any given time,
consistent with our observations here.
Another mechanism to account for the observed decreases
in free barbed ends in the presence of increased Tmod3 lev-
els is that Tmod3 could compete directly with Arp2/3 for
the capture of free pointed ends of actin filaments and oligo-
mers. Both Tmods and Arp2/3 cap ATP-actin with similar
affinities as determined by in vitro pointed-end elongation
assays (this study; Weber et al., 1994, 1999; Blanchoin et
al., 2000b). However, unlike Tmod, which shows little pref-
erence for ATP-actin over ADP-actin (Weber et al., 1999),
Arp2/3 has a 25-fold lower affinity for ADP-actin pointed
ends (Blanchoin et al., 2000b). Thus, endogenous levels of
Tmod3 (0.5 
 
 
 
M in HMEC-1 cells) could strongly compete
with Arp2/3 for ADP-occupied pointed ends, and higher
levels of Tmod3 overexpressed in cells could also compete
with Arp2/3 for ATP or ADP-P
 
i
 
 pointed ends, inhibiting
capture of oligomers by Arp2/3. Interestingly, recent studies
to directly observe actin filament polymerization in vitro
provide evidence that Arp2/3 can capture short actin fila-
ments or oligomers to form new branches (Fujiwara et al.,
2002a), in addition to de novo nucleation of filaments from
the sides of existing ones (Blanchoin et al., 2000a; Amann
and Pollard, 2001).
Cofilin/ADF has been proposed to accelerate the rate of
actin pointed-end disassembly in treadmilling models for
lamellipodia filament turnover by two alternative mecha-
nisms (Pollard et al., 2000). The first is by directly enhanc-
ing the actin off rate from the pointed end (Carlier et al.,
1997), whereas the second is by severing filaments, leading
to more free pointed ends that can depolymerize (Maciver et
al., 1991, Chan et al., 2000), in addition to synergizing with
Arp2/3 to create new barbed ends (Ichetovkin et al., 2002).
Figure 9. Effects of decreased Tmod3 levels by siRNA(Tmod3). 
HMEC-1 cells were transfected with siRNA duplex oligos against 
Tmod3 or mock transfected. Cells were later trypsinized and seeded 
onto either dishes for immunoblot analyses or onto coverslips for 
live cell motility analyses. (A) Immunoblots of equal numbers of 
mock- or siRNA-transfected cells, probed with either anti-Tmod3 
antibodies (top) or C4 anti-actin monoclonal antibodies (bottom). 
(B) Average cell migration velocities measured over 4 h on either 
mock-transfected (n   72) or siRNA-transfected (n   64) cells. Box 
and whisker plots were generated as described in the Materials and 
methods. siRNA(Tmod3)-transfected cells migrate  2  faster than 
mock cells (P   0.001). (C) Quantitation of total free pointed ends 
per cell by DNase I staining. (D) Quantitation of lamellipodial free 
barbed ends by rhodamine–actin incorporation as a ratio of fluorescent 
phalloidin. siRNA(Tmod3)-transfected cells exhibit a 45% increase 
in free barbed ends/F in lamellipodia (n   30 per category; P   0.005) 
and a 70% increase in total free pointed ends (n   22 per category; 
P   0.0069). In C and D, standard error of the mean is indicated.T
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In the first case, the ability of Tmod3 to cap pointed ends
and slow down actin disassembly raises the possibility that
Tmod3 might directly compete for binding to pointed ends
with cofilin/ADF and antagonize its actin pointed-end de-
polymerizing activity. In the second case, the presence of ex-
cess Tmod3 would be expected to cap the newly appearing
pointed ends, thus slowing down actin disassembly. It is dif-
ficult to see how transient capping of pointed ends by
Tmod3 could directly affect cofilin severing of filaments,
which can take place many subunits distant from the
pointed end (Chan et al., 2000). However, if Tmod3 were
to antagonize cofilin/ADF severing, this could also explain
the decrease in the proportion of barbed ends in lamellipo-
dia, which is observed here with increasing Tmod3 levels. In
support of a mechanism where Tmod3 may antagonize cofi-
lin/ADF activity, recently Dawe et al. (2003) reported that
inhibition of cofilin/ADF activity in fibroblasts causes cell
depolarization in a phenotype strikingly similar to the phe-
notype observed by overexpression of Tmod3.
A mechanism for regulation of Tmod3 in endothelial cells
and its effects on lamellipodial actin could be stabilization of
tropomyosin (TM) on Tmod3-capped actin filaments. This
could account for the decrease in lamellipodial free barbed
ends and F-actin upon increased Tmod3 expression, because
TM is known to inhibit both Arp2/3-mediated filament
branching (Blanchoin et al., 2001) and cofilin/ADF-medi-
ated filament severing (DesMarais et al., 2002). Indeed, in
vitro filament depolymerization data suggest that Tmod1
may be able to stabilize TM on the ends of actin filaments
(Weber et al., 1994, 1999). However, neither endogenous
Tmod3 nor GFP–Tmod3 show strong localization to stress
fiber bundles, which are the major TM-coated F-actin struc-
tures in cells (Fig. 3; unpublished data). Conversely, lamelli-
podia have been shown to be lacking in TM (DesMarais et
al., 2002) where Tmod3 was most prominent. In fact, we
have observed that lamellipodia containing GFP–Tmod3
exhibit a paucity of at least some TM isoforms (unpublished
data). These data would suggest that TM does not signifi-
cantly regulate Tmod3 localization, and vice versa.
One of the most conspicuous features of the phenotype
resulting from increased Tmod3 levels is the depolarization
of cells accompanying the decrease in migration rate. Cre-
ation of a protruding leading lamellipodia is critical for the
initiation of polarized cell migration (Borisy and Svitkina,
2000). Although the data presented here demonstrate that
many of the overexpressing cells continue to extend protru-
sions (Video 3), quantitative analyses of protrusion kymo-
graphs indicate that these protrusions show a marked de-
crease in the persistence and efficiency of forward movement
(unpublished data). Recent studies show that effective for-
ward protrusion of the lamellipodium requires coordinated
generation of optimum levels of barbed ends together with
adhesion of cell protrusions (Krause et al., 2002; Mogilner
and Edelstein-Keshet, 2002). Our data suggest that the gen-
eration of free barbed ends is coordinated with pointed-end
disassembly in lamellipodial actin networks. Thus, the loss
of free barbed ends, as an indirect consequence of excess
Tmod3, may lead to loss of polarization by decreasing the
efficiency of forward protrusion. However, despite clear evi-
dence of lamellipodial actin defects in Tmod3-overexpress-
ing cells, we cannot formally rule out additional effects of
Tmod3 on cell adhesion. This is in part due to the difficulty
of parsing the functions of cell adhesion from cell spreading
and protrusion, as both functions are mutually dependent.
Future studies using methods with increased time resolution
to alter capping activity levels (e.g., uncaging experiments,
etc.) coupled with real-time analyses of actin turnover (e.g.,
fluorescent speckle microscopy) may allow better correlation
of actin turnover with lamellipodial protrusion, adhesion,
and polarization.
Materials and methods
Cell culture
HMEC-1 cells were cultured as previously described (Kiosses et al., 1999),
with a few modifications. Cells were maintained in EGM-2 medium
(Clonetics) at 37 C in 7% CO2. For microscopy experiments, cells were
plated on glass coverslips coated overnight with 2  g/ml fibronectin
(Sigma-Aldrich).
Expression of recombinant Tmod proteins 
and adenoviral vectors
Full-length human Tmod3 (U-Tmod) (accession no. AF177172) and hu-
man Tmod1 (E-Tmod) (accession no. AF131836) cDNAs were inserted in
frame in the pGEX-KG vector. GST–Tmods were expressed in Escherichia
coli and affinity purified on a glutathione column, and then Tmods were
released from the GST moiety and purified to homogeneity as previously
described (Babcock and Fowler, 1994). For overexpression studies in
HMEC-1 cells, the full-length cDNA for human Tmod3 was subcloned into
pEGFP (CLONTECH Laboratories, Inc.) to generate the GFP–Tmod3 fusion
cDNA. Adenoviral (Ad) vectors were made as previously described (Alt-
schuler et al., 1998). HMEC-1 cells were infected 12–14 h after plating with
the GFP–Tmod3 Ads together with Ads expressing the tet transcriptional
activator protein (tTA) under control of the murine CMV promoter. Expres-
sion of GFP–Tmod3 was observed by  20 h after infection, and all bio-
chemical assays and in situ stains were performed at 24 h after infection;
live cell data were collected from 22 to 30 h after infection. Cells overex-
pressing GFP–Tmod3 were viable for at least 3 d after onset of expression,
indicating that cytotoxicity was not an issue in our experiments. Overex-
pression controls for the Ad vector were either a virus construct expressing
GFP with the tTA-expressing virus or tTA virus alone. Neither control in-
fection regime produced observable effects on cell morphology or behav-
ior (not depicted). In our experiments, free GFP (unfused) tended to form
bright aggregates in some HMEC-1 cell bodies (not depicted), whereas
GFP fusion proteins did not (Fig. 3). Therefore, for fluorescence experi-
ments, tTA virus alone was used in control infections.
Suppression of Tmod3 expression by RNA interference
Target specific siRNA duplexes were designed as described previously (El-
bashir et al., 2002). Candidate siRNA sequences were compared against
the human genome by BLAST searches to ensure that Tmod3 was the only
sequence targeted. Selected siRNA duplexes were from Dharmacon Re-
search Inc. For experiments described here, the sequence used was AAT-
TGTGTGACCTCGCAGCAATT (437–459 relative to the start codon). To
observe uptake of the duplexes by cells, duplexes were modified with 5 -
fluorescein. Cells were transfected with duplexes using Oligofectamine
(Invitrogen) at 12 and 60 h after plating. Typical transfection rates observed
via the 5 -fluorescein were  70%. Cells were replated onto fibronectin-
coated coverslips (for immunofluorescence or motility studies) or plastic
dishes (for biochemistry) 10–12 h before experiments. As negative con-
trols, cell were either mock transfected (with reagent only) or transfected
with single-stranded DNA oligonucleotides (also 5 -fluorescein labeled;
purchased from Proligo.com).
Antibodies and reagents
Rabbit polyclonal antibodies to gel-purified recombinant human Tmod3
were prepared and affinity purified according to standard procedures. Mono-
clonal antibodies (mAb9) to Tmod1 (E-Tmod) have been previously de-
scribed (Gregorio and Fowler, 1995). Fluorescence-labeled secondary goat
antibodies were from Jackson ImmunoResearch Laboratories. Monoclonal
antibody to actin (C4) was a gift from J. Lessard (University of Cincinnati,
Cincinnati, OH). Polyclonal sera to Arp2/3 was a gift from M. Welch (Uni-T
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versity of California, Berkley, CA). Labeled phalloidin, phallacidin, and flu-
orescent DNase I were from Molecular Probes. Unlabeled phallacidin was
from Sigma-Aldrich. Rhodamine-labeled actin was prepared as previously
described (Littlefield et al., 2001). Fluorescence-labeled DBP was prepared
using purified DBP (Calbiochem) and Alexa Fluor
®546–maleimide (Molec-
ular Probes), according to the manufacturer’s suggestions.
Actin polymerization measurements
Measurements of elongation rates at the pointed end were performed using
8–16% pyrenyl-labeled rabbit skeletal muscle actin and gelsolin-capped
actin filaments as nuclei for polymerization (Weber et al., 1994, 1999).
Capping activities for Tmods were obtained from the initial elongation
rates, measured directly from the slopes of the polymerization traces over
the first 30 s to 1 min. Rates in the presence of Tmod were divided by the
rate for actin in the absence of Tmod, giving a rate/control rate. The Kds for
Tmods were calculated from the x intercept of a double reciprocal plot of
1/(1   [rate/control rate]) versus 1/Tmod concentration.
Cell fractionation and immunoblot analyses
For whole cell lysates, cells were harvested by scraping directly into warm
Laemmli sample buffer and analyzed by SDS-PAGE. For fractionation of
cells into cytoskeleton-associated and soluble pools, cells were lysed with
cold CSK buffer as previously described (Gregorio and Fowler, 1995). Cell
fractions or whole cell lysates were analyzed in immunoblot assays as pre-
viously described (Kuhlman et al., 1996).
Fluorescence staining and quantitation
For general immunofluorescence staining, cells were fixed with fresh 3.7%
paraformaldehyde in cytoskeleton buffer (CB) (Small et al., 1978) for 20
min at room temperature, after which cells were permeabilized with
0.25% Triton in CB buffer for 20 min at room temperature. For p34 stain-
ing, cells were postfixed for 5 min in  20 C methanol before permeabili-
zation. Cells were blocked and stained in blocking buffer (2% goat serum,
1% BSA in CB). F-actin was stained by including BODIPY–phallacidin,
rhodamine–phalloidin, or coumarin–phalloidin (Molecular Probes) with
the secondary antibodies.
Fluorescent DNase I was used to quantitate free pointed ends in HMEC-1
cells as described previously (Chan et al., 2000). To eliminate the DNase I
nuclear staining component, DAPI or TOPRO-3 (Molecular Probes) were
included to identify nuclear regions. The total amount of free pointed ends
per cell observed in the DNase I image was then calculated as the average
intensity (per unit area) of the total cell area minus the nuclear region.
Free barbed ends were visualized using a protocol developed by Sy-
mons and Mitchison (1991). In our hands,  88% of the rhodamine–actin
incorporation per cell was blocked by coincubation of permeabilized cells
with 1  M cytochalasin D (not depicted), indicating that the incorporation
was predominately at free barbed ends, as expected (Symons and Mitchi-
son, 1991). After background correction, intensity data from rhodamine–
actin images was computed as a ratio to intensity data from corresponding
fluorescent phalloidin images. The resulting ratiometric images were used
for line scans or for quantitation of lamellipodial free barbed ends.
Fluorescence-labeled DBP was used as a probe for G-actin (Cao et al.,
1993). Cells were fixed as for immunofluorescence staining described
above, similar to other previously described protocols for G-actin staining
(Cramer et al., 2002). Cells were incubated with 10  g/ml Alexa
®–DBP
and coumarin–phalloidin in blocking buffer for 30 min, followed by rinses
in TBS. In controls in which Alexa
®–DBP was preincubated with stoichio-
metric amounts of monomeric actin, staining was completely blocked (not
depicted), demonstrating that the stain is specific for actin monomers.
Images were obtained using a Carl Zeiss MicroImaging, Inc. Axioskop
microscope with a Carl Zeiss MicroImaging, Inc. Plan Apo 63X (1.4 n.a.)
objective and a Princeton Instruments cooled CCD camera as previously
described (Littlefield et al., 2001). For quantitative analyses, images were
imported into Metamorph 6.0 software (Universal Imaging Corp.). To
quantitate the amount of G-actin, F-actin, or free barbed ends in the lamel-
lipodia, regions of individual lamellipodia were selected by hand using
tools in Metamorph, taking care to avoid selection of ruffled areas. A re-
gion within 0.7  m from the cell edge was defined as the leading edge.
Fluorescence intensity per unit area for each region was then recorded,
and statistical analyses were performed in Excel. To eliminate small varia-
tions in absolute stain intensities, we compared data from within single ex-
periments only and report representatives of each type of experiment.
Live cell microscopy 
For all live cell experiments, cells were filmed on a Nikon Quantum TE300
inverted microscope using phase contrast optics with Nikon objectives.
Cells were maintained in a heated chamber at 37 C on the microscope
stage, in standard culture media supplemented with 10 mM Hepes, pH
7.5, lacking phenol red dye. Images were collected using a Hamamatsu
ORCA II cooled CCD camera (Hamamatsu Corp.) and a Sutter Filter wheel
and shutter mechanism (Sutter Instrument Co.).
Cell motility analyses were performed using low magnification time-
lapse microscopy of random fields of cells over 4 h. Total distance traveled
by each cell was determined by following nuclear positions over time.
Data shown are from a representative experiment of multiple independent
experiments. For all migration experiments, controls and experimentals
from a single experiment were filmed over the same times after plating to
eliminate differences in basal migration rates, as the cells tend to have
slightly lower migration rates with increased time in culture. To score for
protrusive activity, cell boundary regions from frames 30 min apart were
compared (Kiosses et al., 1999). Cells exhibiting less than a 10% change in
occupied area over the observation period were scored as nonprotrusive.
Box and whisker plots of data were generated using software by Analyze-It
Software Ltd., essentially as described previously (Bear et al., 2000). Boxes
show median values (horizontal center line), lower and upper quartiles
(boxes), and confidence intervals around the median (notch in box) (Fig. 4
B; Fig. 9 B). The mean value is represented by  .
Online supplemental material
The supplemental movies (Videos 1–3) are available online at http://
www.jcb.org/cgi/content/full/jcb.200209057/DC1. Video 1 shows GFP–
Tmod3 localizing to the advancing edge of motile HMEC-1 cells (fluores-
cence time-lapse). Video 2 demonstrates control-infected HMEC-1 cell
migration in vitro (phase time-lapse). Video 3 shows GFP–Tmod3-overex-
pressing HMEC-1 migration in vitro (phase time-lapse).
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